MedPath

通化白山药业股份有限公司

Ownership
-
Established
1999-04-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

61

NMPA:61

Drug Approvals

Mecysteine Hydrochloride Tablets

Product Name
盐酸美司坦片
Approval Number
国药准字H22024497
Approval Date
Jan 4, 2024
NMPA

Proglumide Tablets

Product Name
丙谷胺片
Approval Number
国药准字H22020819
Approval Date
Apr 26, 2020
NMPA

Atropine Sulfate Tablets

Product Name
硫酸阿托品片
Approval Number
国药准字H22021133
Approval Date
Apr 26, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H22021363
Approval Date
Apr 26, 2020
NMPA

Hydrochlorothiazide Tablets

Product Name
氢氯噻嗪片
Approval Number
国药准字H22021134
Approval Date
Apr 26, 2020
NMPA

Sodium Houttuyfonate Tablets

Product Name
鱼腥草素钠片
Approval Number
国药准字H22020829
Approval Date
Apr 26, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22021378
Approval Date
Apr 26, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H22020728
Approval Date
Apr 26, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H22021379
Approval Date
Apr 26, 2020
NMPA

Pentoxyverine Citrate Tablets

Product Name
枸橼酸喷托维林片
Approval Number
国药准字H22020731
Approval Date
Apr 26, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.